Journal of Clinical and Translational Hepatology

Papers
(The median citation count of Journal of Clinical and Translational Hepatology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Corrigendum: FOXO1 Alleviates Liver Ischemia-reperfusion Injury by Regulating the Th17/Treg Ratio through the AKT/Stat3/FOXO1 Pathway79
Quzhi Formula Alleviates Nonalcoholic Steatohepatitis by Impairing Hepatocyte Lipid Accumulation and Inflammation via Bip/eIF2α Signaling44
125I Radioactive Particles Drive Protective Autophagy in Hepatocellular Carcinoma by Upregulating ATG9B30
Role of Ras-related Nuclear Protein/Polypyrimidine Tract Binding Protein in Facilitating the Replication of Hepatitis C Virus30
Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure24
Pre-emptive TIPSS in Acute Variceal Bleeding: Current Status, Controversies, and Future Directions22
MRI/PAI Dual-modal Imaging-guided Precise Tracking of Bone Marrow-derived Mesenchymal Stem Cells Labeled with Nanoparticles for Treating Liver Cirrhosis22
Integrin α6 Targeted Near Infrared Fluorescent Imaging and Photoacoustic Imaging of Hepatocellular Carcinoma in Mice22
New Algorithm Rules Out Acute-on-chronic Liver Failure Development within 28 Days from Acute Decompensation of Cirrhosis21
Liver Transplantation Services During the Time of COVID-1920
Symptoms Burden and Health-related Quality of Life in Chinese Patients with Primary Biliary Cholangitis19
Prognostic Relevance of Metabolic Dysfunction-associated Steatohepatitis for Patients with Chronic Hepatitis B18
Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types17
Sarcopenia in Chronic Liver Disease: A Metabolic Perspective17
Patients with AMA/anti-sp100/anti-gp210 Positivity and Cholestasis Can Manifest Conditions Beyond Primary Biliary Cholangitis16
The Impact of Liver Graft Preservation Method on Longitudinal Gut Microbiome Changes Following Liver Transplant: A Proof-of-concept Study16
Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis15
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma15
USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells13
Development and Validation of a Nomogram for Prediction of the Risk of MAFLD in an Overweight and Obese Population13
Serum N-terminal DDR1: A Novel Diagnostic Marker of Liver Fibrosis Severity12
Immunomodulatory and Antiviral Therapy Improved Functional Cure Rate in CHB Patients with High HBsAg Level Experienced NA12
Elevated Liver Enzymes along with Comorbidity Is a High Risk Factor for COVID-19 Mortality: A South Indian Study on 1,512 Patients12
IL2-inducible T-cell Kinase is Required for HBV-induced Type T Interferon Expression and Antiviral Response12
Subnormal Serum Liver Enzyme Levels: A Review of Pathophysiology and Clinical Significance11
RAMP1 Protects Hepatocytes against Ischemia-reperfusion Injury by Inhibiting the ERK/YAP Pathway11
1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure10
Systematic Evaluation of Guidelines for the Diagnosis and Treatment of Hepatitis E Virus Infection10
Effects of Bivalirudin and Unfractionated Heparin on Liver and Renal Function in Chinese Patients with Coronary Artery Disease Undergoing Coronary Angiography with/without Percutaneous Coronary Interv10
Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease10
Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease10
Serum from Acute-on-chronic Liver Failure Patients May Affect Mesenchymal Stem Cells Transplantation by Impairing the Immunosuppressive Function of Cells10
COVID-19 and Liver Transplantation: Challenges and Opportunities9
Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades9
Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 20199
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review9
Predictive Value of Inflammation Biomarkers in Patients with Portal Vein Thrombosis9
Bao-Gan-Xiao-Zhi-Wan Treatment Attenuates Methionine-choline-deficient Diet-induced Metabolic Dysfunction-associated Steatohepatitis in Rats by Modulating the NF-κB Signal Pathway and Autophagy9
Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination9
Effects of Transjugular Intrahepatic Portosystemic Shunt on Renal and Pulmonary Function in Hepatic Decompensation with and without Hepatorenal and Hepatopulmonary Syndromes: A Review9
Integrated Multidisciplinary Management of Alcohol-Associated Liver Disease9
Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases9
ACE Score Identifies HBeAg-negative Inactive Carriers at a Single-point Evaluation, Regardless of HBV Genotype9
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges9
Drug-induced Fatty Liver Disease: Pathogenesis and Treatment8
Assessing Donor Liver Quality and Restoring Graft Function in the Era of Extended Criteria Donors8
Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma8
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis8
Single-cell Technologies Provide Novel Insights into Liver Physiology and Pathology8
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma8
A Multipathogen Bile Sample-based PCR Assay Can Guide Empirical Antimicrobial Strategies in Cholestatic Liver Diseases8
Dopamine Inhibits the Expression of Hepatitis B Virus Surface and e Antigens by Activating the JAK/STAT Pathway and Upregulating Interferon-stimulated Gene 15 Expression8
Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury8
Vaginal Delivery and Breastfeeding Benefit Infant Immune Response to Hepatitis B Vaccine: A Prospective Cohort Study8
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome8
High-intensity Interval Training for the Management of Nonalcoholic Steatohepatitis: Participant Experiences and Perspectives8
Direct-acting Antiviral-induced Transient Recovery of NK Cells in Early-stage Treatment of Chronic Hepatitis C Patients8
L-GrAFT7 has High Accuracy in Predicting Early Allograft Failure after Liver Transplantation: A Multicenter Cohort Study in China8
Targeted Mitochondrial Delivery to Hepatocytes: A Review7
CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis7
Hepatic Alarmins and Mitochondrial Dysfunction under Residual Hyperlipidemic Stress Lead to Irreversible NAFLD7
UMSCs Attenuate LPS/D-GalN-Induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway7
Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists7
Dermcidin Enhances the Migration, Invasion, and Metastasis of Hepatocellular Carcinoma Cells In Vitro and In Vivo7
Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver7
Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City7
Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells7
Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease7
Newcastle Disease Virus/HK84: Next Potential Star for Targeted Immunotherapy of Hepatocellular Carcinoma?7
Differentiating Neonatal Dubin Johnson Syndrome from Biliary Atresia: Start Simply7
Mouse Models for the Study of Liver Fibrosis Regression In Vivo and Ex Vivo7
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis7
STX5 Inhibits Hepatocellular Carcinoma Adhesion and Promotes Metastasis by Regulating the PI3K/mTOR Pathway7
Improving the Conversion Success Rate of Hepatocellular Carcinoma: Focus on the Use of Combination Therapy with a High Objective Response Rate7
Heritable Chronic Cholestatic Liver Diseases: A Review6
Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation6
Prospect of Animal Models for Acute-on-chronic Liver Failure: A Mini-review6
Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic6
High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions6
Comparison of Clinical Characteristics and Outcomes of MAFLD and NAFLD in Chinese Health Examination Populations6
Metabolic Dysregulation and Metabolite Imbalances in Acute-on-chronic Liver Failure: Impact on Immune Status6
Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment6
Cytokine Storm of COVID-19 and its Impact on Patients with and without Chronic Liver Disease6
MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life6
Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease6
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma6
Autoimmune Hepatitis Induced after Treatment of Syphilitic Hepatitis6
Primary Non-HFE Hemochromatosis: A Review6
Expression and Regulatory Network Analysis of Function of Small Nucleolar RNA Host Gene 4 in Hepatocellular Carcinoma5
Application of Cone-beam Computed Tomography in Interventional Therapies for Liver Malignancy: A Consensus Statement by the Chinese College of Interventionalists5
Dramatic Response to Cabozantinib in a Patient with Refractory Hepatocellular Carcinoma with c-MET Amplification5
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research5
Comparison between Liver Cancer Mortality Rates in China and Spain5
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD5
Prognostic Biomarkers for Hepatocellular Carcinoma Based on Serine and Glycine Metabolism-related Genes5
Evaluation of Plasma Neurodegenerative Biomarkers for Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy in Chinese Patients with Hepatic Cirrhosis5
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase5
GPX4 Promoter Hypermethylation Induced by Ischemia/Reperfusion Injury Regulates Hepatocytic Ferroptosis5
Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota5
The Imbalance of Homeostasis in Neutrophil Extracellular Traps is Associated with Portal Vein Thrombosis in Patients with Decompensated Cirrhosis5
Risk of Coronary Artery Disease in Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis5
Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients5
Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease5
2023 Reviewer Acknowledgement5
Investigating the Effect of Metabolic Phenotypes on Health Events in Alcoholic and Nonalcoholic Fatty Liver Disease5
Single-center Experience in the Diagnosis and Treatment of Hepatic Perivascular Epithelioid Cell Neoplasm5
Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease5
Hepatocellular Carcinoma Risk Scores from Modeling to Real Clinical Practice in Areas Highly Endemic for Hepatitis B Infection5
Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements5
Booster Vaccination in Infancy Reduces the Incidence of Occult HBV Infection in Maternal HBsAg-positive Children5
Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis4
A Prognostic Nomogram for Hepatocellular Carcinoma Based on Wound Healing and Immune Checkpoint Genes4
Pediatric Acute Severe Hepatitis of Unknown Origin: What is New?4
Prognostic Factors Related to In-hospital Death in Children with Biliary Atresia: Analysis of a Nationwide Inpatient Database4
Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis4
Krüppel-like Factor 13 Promotes HCC Progression by Transcriptional Regulation of HMGCS1-mediated Cholesterol Synthesis4
Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories4
Gut Microbiota Dysbiosis Strengthens Kupffer Cell-mediated Hepatitis B Virus Persistence through Inducing Endotoxemia in Mice4
Role of Hydrogen Sulfide and Hypoxia in Hepatic Angiogenesis of Portal Hypertension4
Burden of Liver Cancer Attributable to Hepatitis B and Alcohol Globally, in China, and for Five Sociodemographic Index Regions from 1990 to 2021: A Population-based Study4
Mitochondria at the Crossroads of Cholestatic Liver Injury: Targeting Novel Therapeutic Avenues4
Celiac Disease and Elevated Liver Enzymes: A Still Not Fully Defined Pathogenesis4
Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement4
Role of Noncoding RNAs in the Tumor Immune Microenvironment of Hepatocellular Carcinoma4
Molecular Detection of FGFR2 Rearrangements in Resected Intrahepatic Cholangiocarcinomas: FISH Could Be An Ideal Method in Patients with Histological Small Duct Subtype4
Effectiveness and Safety of Tenofovir Amibufenamide in the Treatment of Chronic Hepatitis B: A Real-world, Multicenter Study4
One Year After First Spontaneous Bacterial Peritonitis: Who Survives?4
Development of a Widely Applicable and Simple Prognostic Score for Patients with Acute-on-chronic Liver Failure4
Multifaceted Influence of Histone Deacetylases on DNA Damage Repair: Implications for Hepatocellular Carcinoma4
Serum Iron Overload Triggers the SMAD Pathway and Induces Hepcidin Expression in Hepatocytes through SMURF14
A Simple and Quick Screening Method for Intrapulmonary Vascular Dilation in Cirrhotic Patients Based on Machine Learning4
Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway4
Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver4
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link4
Irreversible Electroporation for Hepatocellular Carcinoma Abutting the Diaphragm: A Prospective Single-center Study4
Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China4
Association of LDLR rs1433099 with the Risk of NAFLD and CVD in Chinese Han Population4
Impact of Living Donor Liver Transplantation on COVID-19 Clinical Outcomes from a Quaternary Care Centre in Delhi4
Development and Validation of an RNA Binding Protein-associated Prognostic Model for Hepatocellular Carcinoma4
Sarcomatoid Intrahepatic Cholangiocarcinoma After Immunotherapy: A Case Report and Review of the Literature4
Diagnostic and Prognostic Value of Protein Post-Translational Modifications in Hepatocellular Carcinoma4
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment4
Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China3
Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism3
Strategies to Prevent Mother-to-child Transmission of Hepatitis B Virus3
Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis3
Role of Exosomal Modulation of Macrophages in Liver Fibrosis3
Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease3
Transjugular Intrahepatic Portosystemic Shunt Linked to Increased Risk of Hepatocellular Carcinoma: A VA Matched Cohort Study3
Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future3
Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis3
A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma3
Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity3
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity3
Clinical Course and Outcome Patterns of Acute-on-chronic Liver Failure: A Multicenter Retrospective Cohort Study3
Transcriptomic Landscape Analysis Reveals a Persistent DNA Damage Response in Metabolic Dysfunction-associated Steatohepatitis Post-dietary Intervention3
CD55 Variant Associated with Pegylated-interferon α Therapy Response in HBeAg-positive Chronic Hepatitis B Patients3
The Reduced Accuracy of Non-invasive Tests for Significant Fibrosis in Chronic Hepatitis B Patients with Metabolic Dysfunction-associated Steatotic Liver Disease3
Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India3
Gut Microbiota and Cytokine Profile in Cirrhosis3
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis3
Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury: A Cohort Study3
Comprehensive Bile Acid Profiling of ABCB4-mutated Patients and the Prognostic Role of Taurine-conjugated 3α,6α,7α,12α-Tetrahydroxylated Bile Acid in Cholestasis3
FOXO1 Alleviates Liver Ischemia-reperfusion Injury by Regulating the Th17/Treg Ratio through the AKT/Stat3/FOXO1 Pathway3
Premorbid Steatohepatitis Increases the Seriousness of Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice3
Selective Androgen Receptor Modulators: An Emerging Liver Toxin3
Impact of Proteinuria on Liver Enzyme Levels3
Genetics of Gallstone Disease and Their Clinical Significance: A Narrative Review3
Role of Fibrinogen-like Protein 1 in Tumor Recurrence Following Hepatectomy3
Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic Mechanisms3
Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms3
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version)3
Novel Approaches to Inhibition of HBsAg Expression from cccDNA and Chromosomal Integrants: A Review3
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment3
Development and Validation of a Nomogram for 90-day Outcome in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure3
BTF3L4 Overexpression Mediates APAP-induced Liver Injury in Mouse and Cellular Models3
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B3
Dose-dependent Relationship between Alcohol Consumption and the Risks of Hepatitis B Virus-associated Cirrhosis and Hepatocellular Carcinoma: A Meta-analysis and Systematic Review2
Causal Relationship Between Gut Microbiota and Liver Cirrhosis: 16S rRNA Sequencing and Mendelian Randomization Analyses2
Development and Validation of a New Prognostic Model for Predicting Survival Outcomes in Patients with Acute-on-chronic Liver Failure2
Augmenter of Liver Regeneration Monoclonal Antibody Promotes Apoptosis of Hepatocellular Carcinoma Cells2
Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review2
Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma2
Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry2
B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection2
Emerging Evidence Linking the Liver to the Cardiovascular System: Liver-derived Secretory Factors2
Effects of Low-dose and High-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy2
Identification and Validation of the Hsa_circ_0001726/miR-140-3p/KRAS Axis in Hepatocellular Carcinoma Based on Microarray Analyses and Experiments2
Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice2
CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop2
Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM2
Development and Validation of a Clinical Risk Score to Predict Immune-mediated Liver Injury Caused by Sintilimab: Assessed for Causality Using Updated RUCAM2
Nonalcoholic Fatty Liver Disease after Liver Transplant2
SGLT-2 Inhibitor and GLP-1 Receptor Agonist Treatment for Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Is Their Combination the Optimal Treatment Option?2
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment2
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis2
Decoding 17-Beta-hydroxysteroid Dehydrogenase 13: A Multifaceted Perspective on Its Role in Hepatic Steatosis and Associated Disorders2
2022 Reviewer Acknowledgement2
Seronegative Autoimmune Hepatitis2
Giant Hepatic Regenerative Nodule in a Patient With Hepatitis B Virus-related Cirrhosis2
Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases2
Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF2
COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence2
A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis2
A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates2
Clinical Prediction Models for Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Technical Report2
Systematic Training of Liver Imaging Reporting and Data System Magnetic Resonance Imaging v2018 can Improve the Diagnosis of Hepatocellular Carcinoma for Different Radiologists2
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)2
Trends in Mortality of Cirrhosis in China: An Analysis of the China Death Surveillance Database from 2008 to 20202
Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study2
Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease2
KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis2
Single-cell RNA-seq Revealed that Altered Tumor Infiltrating Lymphocytes in Cirrhotic Liver Indicate Development of Hepatocellular Carcinoma2
Regulatory Effect of JAK2/STAT3 on the Immune Function of Endotoxin-tolerant Dendritic Cells and its Involvement in Acute Liver Failure2
Development of an Eight-gene Prognostic Model for Overall Survival Prediction in Patients with Hepatocellular Carcinoma2
Ablation for Benign Liver Tumors: Current Concepts and Limitations2
High Levels of Vitamin C Intake Modify Effects of Phthalates on Metabolic Dysfunction-associated Steatotic Liver Disease: A Nationally Representative Study2
Alcoholic Liver Disease in China: A Disease Influenced by Complex Social Factors That Should Not Be Neglected2
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review2
Value of Non-tumoral Liver Volume in the Prognosis of Large Hepatocellular Carcinoma Patients After R0 Resection2
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome2
Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses2
Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis2
Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation: DELTA Study2
SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites2
A Novel mRNA Signature Related to Immunity to Predict Survival and Immunotherapy Response in Hepatocellular Carcinoma2
Evaluation of GALAD Score in Diagnosis and Follow-up of Hepatocellular Carcinoma after Local Ablative Therapy2
Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis2
A Novel Backward Stepwise Logistic Regression and Classification and Regression Tree Model to Predict 180-day Clinical Outcomes in Hepatitis B Virus-Acute-on-Chronic Liver Failure Patients2
Chinese Clinical Practice Guidelines for the Prevention and Treatment of Mother-to-child Transmission of Hepatitis B Virus (Version 2024)2
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence2
Ferrochelatase Gene Variants Associated with Cholestasis in Adults: A Case Report2
Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?2
P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis2
Cardiac Syndromes in Liver Disease: A Clinical Conundrum2
Clinical and Genetic Characteristics of Alagille Syndrome in Adults2
The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis2
Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI2
Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition – More Than Just ROS-inhibition2
Astragalus Polysaccharide Enhances Voriconazole Metabolism under Inflammatory Conditions through the Gut Microbiota2
Primary Hepatic Extra-gastrointestinal Stromal Tumors: Molecular Pathogenesis, Immunohistopathology, and Treatment1
Unraveling the Dynamic Role of Microtubules in the HBV Life Cycle1
Preclinical Long-term Magnetic Resonance Imaging Study of Silymarin Liver-protective Effects1
Corrigendum: RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma1
Journal of Clinical and Translational Hepatology Receives Its First Impact Factor (4.108) and CiteScore (6.7)1
The Rising Burden of Hepatocellular Carcinoma: Is the Gender Gap Narrowing?1
Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma1
Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?1
MALAT1-mediated EZH2 Recruitment to the GFER Promoter Region Curbs Normal Hepatocyte Proliferation in Acute Liver Injury1
Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma1
0.10694885253906